This study involved 221 microfilaremic (Mf+), 302 amicrofilaremic (Mf-) antigen positive (AG+) and 1454 Mf-antigen negative (AG-) individuals living in endemic villages. Whatever the group considered, antigen and antibody titers were widely distributed. Og4C3 antigen, detected both in Mf- and Mf+ patients, was significantly higher in Mf+ patients. The Mf parasitological status did not significantly influence the antifilarial antibodies levels in the infected AG+ individuals, although IgG4 was more discriminant. In the supposedly uninfected individuals (Mf-AG-), anti-filarial IgG and IgG4 could be detected in a large proportion of the group. Og4C3 circulating antigen test was confirmed to be a good marker of active Wuchereria bancrofti infection.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Occurrence of Lymphatic Filariasis infection after 15 years of mass drug administration in two hotspot districts in the Upper East Region of Ghana.
PLoS Negl Trop Dis
August 2022
Faculty of Allied Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Article Synopsis
- - A study in Ghana evaluated the impact of 15 years of mass drug administration (MDA) on lymphatic filariasis (LF), revealing CFA prevalence rates of 19.6% in Kassena Nankana East Municipal (KNEM) and 12.8% in Nabdam, with significant regional variation.
- - Out of 7,453 participants, the Og4C3 antigen was present in about 22.6% of selected individuals, while only 0.7% showed microfilariae, indicating a need for further testing methods against the existing WHO threshold for LF elimination.
- - Despite not meeting the original 2020 elimination target, the study suggests intensifying MDA efforts focused on
[Evaluation of the Filaria Detect™ IgG4 kit employing recombinant Wb123 antigen for diagnosis of lymphatic filariasis in BrazilEvaluación del estuche Detect™ para pruebas de anticuerpos antifiláricos IgG4, fabricado con el antígeno recombinante Wb123, para el diagnóstico de la filariasis linfática en Brasil].
Rev Panam Salud Publica
July 2021
Universidade Federal de Pernambuco (UFPE), Programa de Pós-Graduação em Medicina Tropical Recife (PE) Brasil Universidade Federal de Pernambuco (UFPE), Programa de Pós-Graduação em Medicina Tropical, Recife (PE), Brasil.
The Global Programme to Eliminate Lymphatic Filariasis, launched by the World Health Organization in the year 2000, proposes the use of circulating filarial antigen tests as a diagnostic tool to assess and monitor initiatives to control filarial infection. However, despite a high sensitivity, these tests are not efficient to detect infection at early stages, before worms have reached the adult stage. Considering this limitation, anti-filarial antibody testing has been suggested as an alternative, given that the antibodies produced against the larvae are detectable before the presence of circulating filarial antigen.
View Article and Find Full Text PDFCharacterization of glycan determinants that mediate recognition of the major Wuchereria bancrofti circulating antigen by diagnostic antibodies.
Mol Biochem Parasitol
November 2020
Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
The Global Program to Eliminate Lymphatic Filariasis (GPELF) relies heavily on a rapid diagnostic test (RDT) to a Wuchereria bancrofti circulating filarial antigen (Wb-CFA) to identify endemic areas and for determining when mass drug administration can stop. The antigen contains a carbohydrate epitope that is recognized by monoclonal antibody AD12. Og4C3, a monoclonal antibody that is used in a commercial ELISA for Wb-CFA recognizes the same moiety.
View Article and Find Full Text PDFEffectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil.
Pathog Glob Health
July 2018
a Oswaldo Cruz Fundation , Aggeu Magalhães Institute, National Center of Lymphatic Filariasis, Recife , Pernambuco , Brazil.
The Global Program to Eliminate Lymphatic Filariasis has achieved extraordinary success in reducing transmission and preventing morbidity through mass drug administration (MDA) to the population at-risk. Brazil is the only currently using diethylcarbamazine citrate (DEC) alone for MDA, so an assessment of its effectiveness is needed. We report the trends of filarial markers in a cohort of 175 individuals infected with Wuchereria bancrofti in areas that underwent MDA in the city of Olinda, Northeastern Brazil.
View Article and Find Full Text PDFChiluria in a lymphatic filariasis endemic area.
BMC Res Notes
May 2018
Instituto Aggeu Magalhaes, FIOCRUZ, Av. Prof. Moraes Rego 1235, Recife, 50670-901, Brazil.
Objective: To establish clinical and laboratory data of individuals presenting chyluria in endemic areas.
Results: 75 individuals were studied. The majority were females with an average age of 45 years residing in the Metropolitan Region of Recife.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!